Tech Xplore

Generative AI designs DNA origami to match user-drawn shapes automatically

A joint research team has developed an automated design technology that enables the creation of DNA origami structures that ...
Christianity Today

The Algorithm Is Changing How We Speak—and Strive

“Algospeak” capitalizes on our desire for attention and status. We should turn to God for both. I’ll typically start formulating ideas around 7 a.m. Thanks to a steady stream of information from my ...
CNN

I ran 50+ miles in New Balance’s newest fashion-forward running shoes. Here’s whether they feel as good as they look

New Balance running shoes have been a staple in my sneaker rotation for years — I have 11 pairs in my closet right now — but given the brand’s tendency to release new iterations of its existing styles ...
Women's Health

This New Sneaker Helped Me Find My Love of Running Again—Now, I’ll Never Travel Without Them

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? One thing about me is that I love running—like, genuinely love it. But, ...
Los Angeles Times

Gen Z is the loneliest generation. Here’s what can help

This is read by an automated voice. Please report any issues or inconsistencies here. See more from the L.A. Times in Google Search. Set us as preferred We are more connected than ever before, with ...
Forbes

Generate Biomedicines IPO Turns Heads

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...
Runner's World

New Balance’s new Ellipse running shoe is built for comfort – here’s my review

It seems like the buzziest running shoes launches of late put an emphasis on pace, performance and carbon plates. However, the latest shoe in the New Balance running portfolio, the Ellipse, takes a ...
Wall Street Journal

A New Lost Generation: Why Gen Z Is Unprepared for the Workplace

The workplace can be a tricky place to navigate. Almost everything we do at work—identifying the experts, managing tough feedback from a boss, figuring out how to work in teams made up of different ...
FierceBiotech

Behind Generate's 'feverish' race to raise $400M IPO while window remains open

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...
Bloomberg L.P.

Flagship-Backed Generate Biomedicines Raises $400 Million in IPO

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...
Reuters

Drug developer Generate Biomedicines raises $400 million in US IPO

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...